Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity
British journal of surgery2004Vol. 91(12), pp. 1613–1618
Citations Over TimeTop 13% of 2004 papers
Ronan A. Cahill, Katherine M. Sheehan, Robert Scanlon, Frank E. Murray, Elaine W. Kay, H. P. Redmond
Abstract
Although beneficial in the treatment of pathological inflammation, selective COX-2 inhibitors may adversely affect colonic anastomotic healing.
Related Papers
- → The effect of the withdrawal of rofecoxib on prescribing patterns of COX‐2 inhibitors in Scotland(2006)21 cited
- → Rofecoxib and Clinically Significant Upper and Lower Gastrointestinal Events Revisited Based on Documents From Recent Litigation(2011)14 cited
- → Chemoprevention of intestinal polyposis in the APCΔ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor(2000)13 cited
- Reflections on the withdrawal of rofecoxib : editorial(2005)
- Analysis of withdrawal of rofecoxib-cyclooxygenase-2 specific inhibitor(2005)